Literature DB >> 34369565

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus.

Ying Liu1, Joacim Rocklöv2.   

Abstract

Entities:  

Keywords:  Alpha variant; B1.617.2; COVID-19; Delta variant; R0; SARS-CoV-2; Wuhan; basic reproductive number; epidemic potential; pandemic; transmissibility; variants of concerns

Mesh:

Year:  2021        PMID: 34369565      PMCID: PMC8436367          DOI: 10.1093/jtm/taab124

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
SARS-CoV-2 variants of concerns (VOC) evolve in countries or areas with high virus circulation and low vaccine coverage rates. According to the World Health Organization, VOC are defined as virus variants for which there is evidence of an increase in transmissibility, more severe disease (e.g. increased hospitalizations or deaths), significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures. The Alpha (B.1.1.7) variant emerged in the UK and was the first VOC to show higher transmissibility than the ancestral strain, rapidly becoming the dominating VOC from January 2021 onwards. The Delta (B.1.617.2) variant emerged in India at a time of low vaccine coverage and high transmission rates and is now replacing all other SARS-CoV-2 variants, fuelling outbreaks in countries that had previously been able to suppress COVID-19 outbreaks and also causing resurgence in countries even with highly vaccinated populations. In this study, we review the basic reproductive number (R0) of the Delta variant contrasting it to the early estimates of R0 of the ancestral strain from the pre-pandemic outbreak phase.  R0 gives an indication of the epidemic potential of a virus, by representing the average number of new infections generated by an infectious person in a totally naïve population in the absence of effective control and vaccines. It basically transforms the contact rate and the transmissibility of an infectious pathogen into a threshold condition describing the longer-term prospects of the pathogen circulation. To put it simply, if R0 > 1, the epidemic will grow, and if R0 < 1, the epidemic will reverse. We searched for eligible studies in PubMed, bioRxiv, medRxiv, Baidu, CNKI and Wanfang database covering the period from 1 January 2020 to 30 July 2021, in both English and Chinese language. Given the novelty of this variant, we just used broad search terms which included (Delta) OR (B.1.617.2). We had 15 170 hits in PubMed, 1032 in MedRxiv and 13 286 through bioRxiv. We identified five studies, which estimated the basic reproductive number for Delta. Table 1 shows that the basic reproductive number for Delta ranged from 3.2 to 8, with a mean of 5.08. Supplementary Figure S1 in Appendix displays the published R0 estimates for the Delta variant and ancestral strain.
Table 1

Published estimates of R0 for the Delta variant of SARS-CoV-2

First author (study reference)LocationStudy dateMethods R 0 estimates95% CI
Meng Zhang (Meng Zhang, Jianpeng Xiao, Aiping Deng, Yingtao Zhang, Yali Zhuang, Ting Hu, Jiansen Li, Hongwei Tu, Bosheng Li, Yan Zhou, Jun Yuan, Lei Luo, Zimian Liang, Youzhi Huang, Guoqiang Ye, Mingwei Cai, Gongli Li, Bo Yang, Bin Xu, Ximing Huang, Yazun Cui, Dongsheng Ren, Yanping Zhang, Min Kang, Yan Li. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2—Guangdong Province, China, May–June 2021[J]. China CDC Weekly, 2021, 3(27): 584–586. doi: 10.46234/ccdcw2021.148)Guangdong Province, ChinaMay–June 2021Maximum likelihood method3.22.0–4.8
Qingfeng Shi (Qingfeng Shi, Xiaodong Gao, Bijie Hu. Research progress on characteristics, epidemiology and control measure of SARS-CoV-2 Delta VOC. Chin J Nosocomiol Vol.31, 2021)Guangdong Province, ChinaAfter 21 May 2021/4.04–5.0/
SPI-M-O (SPI-M-O: Summary of further modelling of easing restrictions—roadmap Step 4)Englandbefore 9 June, 2021SPI-M-O’s modelling5–8/
David Mackie (David Mackie, J.P. Morgan. Global vulnerabilities to the COVID-19 variant B.1.617.2. SUERF Policy Briefs No 110, June 2021)UKMay 2021Assuming the secondary attack rate of Delta excluding the impact of NPIs and vaccinations was around 4.29%5.2/
Hengcong Liu (Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, Juan Yang, Qianhui Wu, Zhiyuan Chen, Wen Zheng, Cécile Viboud, Wenhong Zhang, Marco Ajelli, Hongjie Yu. Herd immunity induced by COVID-19 vaccination programs to suppress epidemics caused by SARS-CoV-2 wild type and variants in China. medRxiv 2021.07.23.21261013. 10.1101/2021.07.23.21261013)ChinaJuly 2021Based on the transmissibility of the Delta variant is 50% higher as compared with that of the Alpha variant6/
Averaged 5.08
Published estimates of R0 for the Delta variant of SARS-CoV-2 An R0 of 5.08 is much higher than the R0 of the ancestral strain with a R0 of 2.79, which was the estimated median R0 in Liu et al.’s review study based on 14 estimates of the ancestral strain. With an R0 of 5.08, Delta also has a much higher reproductive number compared to other viral infections such SARS, MERS, smallpox, Ebola, seasonal influenza and pandemic influenza. Delta infections are associated with higher viral loads and longer duration of shedding causing higher transmissibility and R0, and also lower vaccine effectiveness affecting the effective reproduction number impacted by disease control, Re. Delta variant may possibly also cause more severe disease with higher odds of hospitalization, ICU admission and death. Given its high reproductive number associated with higher transmissibility, in a context of globally still, low vaccine coverage rates and lower vaccine effectiveness, public health and social measures will need to be substantially strengthened to combat this emerging variant, with more stringent measures required compared to the ancestral SARS-CoV-2 strains and other variants. A high reproductive number also means that much higher vaccine coverage rates need to be achieved compared to the originally assumed 60–70% vaccine coverage for the ancestral strain. A reproductive number of 5 would mean that vaccine coverage rates above 80% will be needed based on the equation q = 1–1/R0, assuming a 100% vaccine efficacy. However, with decreasing vaccine effectiveness associated with the Delta variant, vaccine coverage rates above 90% will need to be achieved to contain Delta outbreaks. Fortunately, vaccine effectiveness against severe disease remains relatively maintained, while mild-to-moderate breakthrough infections in vaccinated persons have increased as the result of the emergence of the Delta variant. Given that the reproductive number in the studies identified here was estimated at a time when most countries still enforce a variable extent of lockdown measures, there is a risk that the real reproductive number may be even higher than the estimated 5.08. Rapidly ramping up vaccine coverage rates globally while maintaining or enhancing public health and social measures is now even more urgent and important in the era of the Delta variant. Click here for additional data file.
  143 in total

1.  Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.

Authors:  Adeel A Butt; Soha R Dargham; Hiam Chemaitelly; Abdullatif Al Khal; Patrick Tang; Mohammad R Hasan; Peter V Coyle; Anil G Thomas; Abdelsalam M Borham; Elli G Concepcion; Anvar H Kaleeckal; Ali Nizar Latif; Roberto Bertollini; Abdul-Badi Abou-Samra; Laith J Abu-Raddad
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 21.873

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

Review 3.  Molecular adaptations during viral epidemics.

Authors:  Nash D Rochman; Yuri I Wolf; Eugene V Koonin
Journal:  EMBO Rep       Date:  2022-07-18       Impact factor: 9.071

4.  Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data.

Authors:  Sarah Mullin; Brent Vander Wyk; Jennifer L Asher; Susan R Compton; Heather G Allore; Caroline J Zeiss
Journal:  PNAS Nexus       Date:  2022-07-01

5.  Optimal vaccination at high reproductive numbers: sharp transitions and counterintuitive allocations.

Authors:  Nir Gavish; Guy Katriel
Journal:  Proc Biol Sci       Date:  2022-09-28       Impact factor: 5.530

6.  Hesitancy towards the Third Dose of COVID-19 Vaccine among the Younger Generation in Japan.

Authors:  Mostafa Saidur Rahim Khan; Trinh Xuan Thi Nguyen; Sumeet Lal; Somtip Watanapongvanich; Yoshihiko Kadoya
Journal:  Int J Environ Res Public Health       Date:  2022-06-08       Impact factor: 4.614

7.  PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.

Authors:  Viviana Simon; Vamsi Kota; Ryan F Bloomquist; Hannah B Hanley; David Forgacs; Savita Pahwa; Suresh Pallikkuth; Loren G Miller; Joanna Schaenman; Michael R Yeaman; David Manthei; Joshua Wolf; Aditya H Gaur; Jeremie H Estepp; Komal Srivastava; Juan Manuel Carreño; Frans Cuevas; Ali H Ellebedy; Aubree Gordon; Riccardo Valdez; Sarah Cobey; Elaine F Reed; Ravindra Kolhe; Paul G Thomas; Stacey Schultz-Cherry; Ted M Ross; Florian Krammer
Journal:  mSphere       Date:  2022-05-19       Impact factor: 5.029

8.  Development of a Test System to Detect the Omicron Variant of SARS-CoV-2 and the Frequency of Its Detection in Patients.

Authors:  M L Filipenko; I P Oskorbin; D V Shamovskaya; E A Kharpov; A A Stepanov; V V Romanov; V V Kuznetsov; U A Boyarskikh; A A Kechin; E V Pechkovsky; A B Krivoruchko; A M Ivanov; N E Kushlinskii; V V Vlasov
Journal:  Bull Exp Biol Med       Date:  2022-06-23       Impact factor: 0.737

9.  COVID-19 booster vaccine attitudes and behaviors among university students and staff in the United States: The USC Trojan pandemic research Initiative.

Authors:  Ryan C Lee; Howard Hu; Eric S Kawaguchi; Andre E Kim; Daniel W Soto; Kush Shanker; Jeffrey D Klausner; Sarah Van Orman; Jennifer B Unger
Journal:  Prev Med Rep       Date:  2022-06-27

10.  SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.

Authors:  Fadi AlJamaan; Mohamad-Hani Temsah; Khalid Alhasan; Shuliweeh Alenezi; Ali Alhaboob; Abdulkarim Alrabiaah; Mohammed Batais; Fatimah Alshahrani; Rasha Asaad Assiri; Hind Bafaqih; Ali Alaraj; Bedoor Al Qadrah; Abdulilah Alhaidary; Khaled Saad; Basema Saddik; Rabih Halwani; Ali A Rabaan; Sarah Al-Subaie; Mazin Barry; Jaffar A Al-Tawfiq
Journal:  J Infect Public Health       Date:  2022-06-17       Impact factor: 7.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.